Observational studyClinical drug investigation2016

Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain.

María Del Carmen Vennera et al.PubMed ↗Publisher ↗

No numbers read from the abstract.